Advanced search

Sassine Ghazi is Chief Operating Officer of Synopsys, Inc. He received an undergraduate degree from Lebanese American University, an undergraduate degree from Georgia Institute of Technology and a graduate degree from the University of Tennessee.

Joseph Sassine currently works as a Director at Banque de l'Habitat SAL.

Andrew H.
Sassine is currently the Chief Financial Officer & Director at Arcturus Therapeutics, Inc., the Chief Financial Officer & Director at Arcturus Therapeutics Ltd., and the Chief Financial Officer & Director at Arcturus Therapeutics Holdings, Inc. He is also an Independent Director at iCAD, Inc. In the past, he served as an Independent Non-Employee Director at MYnd Analytics, Inc., an Independent Director at Acorn Energy, Inc., a Director at Meditech, Inc., a Director at Freedom Meditech, Inc., an Independent Director at FluoroPharma Medical, Inc., a Director at ComHear, Inc., a Director at MD Revolution, Inc., and an Independent Director at Gemphire Therapeutics, Inc. He also held positions at Exicure, Inc., Continental Bank Corp., Fidelity Management & Research Co. LLC, Heller Financial, Inc., Fleet Bank of Massachusetts, NA, and Fleet National Bank.
Mr. Sassine received his undergraduate degree from the University of Iowa, an MBA from The Wharton School of the University of Pennsylvania, and another undergraduate degree from Tippie College of Business.

Saliba Sassine was the founder of Rhinomed Ltd.
(founded in 2003) and served as the Non-Executive Chairman in 2011.
Dr. Sassine is also the founder of Biotech International Ltd.
Dr. Sassine's current jobs include Chairman at SA Capital Pty Ltd., Gold Mines of Peru Ltd., Perth Theatre Trust, POWA Institute, Perth Theatre Co., Boyuan Holdings Ltd.
(since 2015), Director at Western Australian Academy of Performing Arts, and Managing Director at BlueMount Capital (WA) Pty Ltd.
Dr. Sassine is also a Senior Associate Member at Securities Institute of Australia since 2011.
Dr. Sassine's former jobs include Chairman at Allegra Capital Pty Ltd.
and AusBiotech Ltd., Non-Executive Chairman at Motio Ltd.
(2013), Independent Director at Pepcap Resources, Inc. (2015-2017), Non-Executive Director at Visiomed Group Pty Ltd., Director at PYC Therapeutics Ltd., and Non-Executive Director at Zeotech Ltd.
(2012-2013).
Dr. Sassine obtained undergraduate and doctorate degrees from The University of Western Australia.

Mr. Steven Sassine, CFA, is an Associate Analyst at Morgans Financial Ltd.
He has over 11 years experience in the Australian equities market.
He has worked in the front office of CommSec, servicing its 'High Value Client' base as well as CBA's Institutional business.
Prior to joining Morgans, he was a trader at BTIG Australia.
He received a Bachelor of Commerce from University of Sydney and he is a CFA charterholder.

Victoria Sassine is the founder and CEO of Scale Smarter Partners, LLC, which was founded in 2018.
She is currently an Independent Director at AMG Pantheon Fund LLC since 2014, a Director at AMG Pantheon Master Fund LLC, and a Director at PRG Group, Inc. since 2017.
Ms. Sassine was formerly the Chairman of Business Management Associates, Inc. from 2018 to 2019.